Surface modification of pig endothelial cells with a branched heparin conjugate improves their compatibility with human blood
Anjan K Bongoni, Evelyn Salvaris, Sofia Nordling, Nikolai Klymiuk, Eckhard Wolf, David L Ayares, Robert Rieben, Peetra U Magnusson, Peter J Cowan
Scientific Reports | NATURE PUBLISHING GROUP | Published : 2017
Awarded by Swiss National Science Foundation (SNSF)
Awarded by Research Endowment Fund of St Vincent's Hospital Melbourne
Awarded by National Health & Medical Research Council of Australia (NHMRC) - European Union (EU) Collaborative Research program
These studies were supported by the Swiss National Science Foundation (SNSF) (Fellowship: P2BEP3_155459), the Research Endowment Fund of St Vincent's Hospital Melbourne (REF# 70189), and the National Health & Medical Research Council of Australia (NHMRC) - European Union (EU) Collaborative Research program (project #1074171). The authors thank Annegret Wuensch, Andrea Baehr from the Institute of Molecular Animal Breeding and Biotechnology, Ludwig-Maximilian University, Munich, Germany for providing aortic endothelial cells from genetically modified pigs. The authors also thank staff at the Immunology Research Centre (IRC), St. Vincent's Hospital Melbourne, Australia, for technical support and advice.